Chronic obstructive pulmonary disease is associated with a higher incidence of acute kidney injury in non-cardiac but not in cardiac surgery ICU-patients: a retrospective MIMIC-III database analysis
Nadine Hochhausen , Ajay Moza , Andreas Kroh , Rolf Rossaint , Felix Kork
{"title":"Chronic obstructive pulmonary disease is associated with a higher incidence of acute kidney injury in non-cardiac but not in cardiac surgery ICU-patients: a retrospective MIMIC-III database analysis","authors":"Nadine Hochhausen , Ajay Moza , Andreas Kroh , Rolf Rossaint , Felix Kork","doi":"10.1016/j.rmed.2025.108160","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Acute kidney injury (AKI) and chronic obstructive pulmonary disease (COPD) are both associated with high mortality. We hypothesized that COPD impacts the incidence of AKI and the outcome of surgical intensive care unit (ICU)-patients.</div></div><div><h3>Materials and methods</h3><div>We analyzed data of surgical ICU-patients from the Medical-Information-Mart-for-Intensive-Care-III-database. We compared the incidence of AKI, in-hospital-mortality, ICU-and hospital-length-of-stay (ICU-LOS, HLOS) in patients with and without COPD. In a subgroup analysis, we compared the outcomes of patients undergoing cardiac (CS) and non-cardiac surgery (NCS).</div></div><div><h3>Results</h3><div>The data of 21,720 cases were analyzed, 9.7 % suffered from COPD. COPD-patients were younger compared to patients without COPD (64years(52–75)vs.71years(63–78),p < 0.001). Males were more frequently represented in both groups (58.3 %vs.61.2 %,p = 0.009). COPD-patients had a higher incidence of AKI (24.2 %vs.19.7 %,p < 0.001), higher in-hospital-mortality (8.7 % vs.6.4 %,p < 0.001), longer ICU-LOS (3.1days(IQR,1.6–7.0)vs.2.3days(IQR,1.3–5.0),p < 0.001), and HLOS (10days(IQR,6–17)vs.8days(IQR,5–15),p < 0.001). Multivariable analyses could not confirm a higher risk for AKI in surgical COPD-patients but for all other outcomes (in-hospital mortality,OR:1.59,95 %CI:1.24–2.04,p < 0.001; ICU-LOS,beta:1.1, 95 %CI:0.6–2.3,p < 0.001; HLOS,beta:1.7,95 %CI:0.9–2.4,p < 0.001).</div><div>Subgroup analyses revealed that COPD was associated with a higher risk of AKI (OR,1.24,95 %CI:1.01–1.51,p = 0.038), longer ICU-LOS (beta:0.9,95 %CI:0.3–1.5,p = 0.006) and HLOS (beta:1.4,95 %CI:0.2–2.5,p = 0.018) but not with a higher risk for in-hospital mortality in NCS-patients. In CS-patients on the other hand, COPD was associated with a higher risk for in-hospital mortality (OR,1.73,95 %CI:1.02–2.94,p = 0.043) but neither for AKI, longer ICU-LOS or HLOS.</div></div><div><h3>Conclusions</h3><div>COPD has a different impact on outcomes in CS- and NCS-patients. While COPD was associated with a higher risk for in-hospital mortality in CS-patients, COPD was associated with a higher risk of AKI, longer ICU-LOS and HLOS in NCS-patients.</div></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":"244 ","pages":"Article 108160"},"PeriodicalIF":3.5000,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0954611125002227","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose
Acute kidney injury (AKI) and chronic obstructive pulmonary disease (COPD) are both associated with high mortality. We hypothesized that COPD impacts the incidence of AKI and the outcome of surgical intensive care unit (ICU)-patients.
Materials and methods
We analyzed data of surgical ICU-patients from the Medical-Information-Mart-for-Intensive-Care-III-database. We compared the incidence of AKI, in-hospital-mortality, ICU-and hospital-length-of-stay (ICU-LOS, HLOS) in patients with and without COPD. In a subgroup analysis, we compared the outcomes of patients undergoing cardiac (CS) and non-cardiac surgery (NCS).
Results
The data of 21,720 cases were analyzed, 9.7 % suffered from COPD. COPD-patients were younger compared to patients without COPD (64years(52–75)vs.71years(63–78),p < 0.001). Males were more frequently represented in both groups (58.3 %vs.61.2 %,p = 0.009). COPD-patients had a higher incidence of AKI (24.2 %vs.19.7 %,p < 0.001), higher in-hospital-mortality (8.7 % vs.6.4 %,p < 0.001), longer ICU-LOS (3.1days(IQR,1.6–7.0)vs.2.3days(IQR,1.3–5.0),p < 0.001), and HLOS (10days(IQR,6–17)vs.8days(IQR,5–15),p < 0.001). Multivariable analyses could not confirm a higher risk for AKI in surgical COPD-patients but for all other outcomes (in-hospital mortality,OR:1.59,95 %CI:1.24–2.04,p < 0.001; ICU-LOS,beta:1.1, 95 %CI:0.6–2.3,p < 0.001; HLOS,beta:1.7,95 %CI:0.9–2.4,p < 0.001).
Subgroup analyses revealed that COPD was associated with a higher risk of AKI (OR,1.24,95 %CI:1.01–1.51,p = 0.038), longer ICU-LOS (beta:0.9,95 %CI:0.3–1.5,p = 0.006) and HLOS (beta:1.4,95 %CI:0.2–2.5,p = 0.018) but not with a higher risk for in-hospital mortality in NCS-patients. In CS-patients on the other hand, COPD was associated with a higher risk for in-hospital mortality (OR,1.73,95 %CI:1.02–2.94,p = 0.043) but neither for AKI, longer ICU-LOS or HLOS.
Conclusions
COPD has a different impact on outcomes in CS- and NCS-patients. While COPD was associated with a higher risk for in-hospital mortality in CS-patients, COPD was associated with a higher risk of AKI, longer ICU-LOS and HLOS in NCS-patients.
期刊介绍:
Respiratory Medicine is an internationally-renowned journal devoted to the rapid publication of clinically-relevant respiratory medicine research. It combines cutting-edge original research with state-of-the-art reviews dealing with all aspects of respiratory diseases and therapeutic interventions. Topics include adult and paediatric medicine, epidemiology, immunology and cell biology, physiology, occupational disorders, and the role of allergens and pollutants.
Respiratory Medicine is increasingly the journal of choice for publication of phased trial work, commenting on effectiveness, dosage and methods of action.